Biomark Diagnostics Inc total revenue, net income and dynamics of changes in Canadian dollar today
Biomark Diagnostics Inc current income in Canadian dollar. Net revenue of Biomark Diagnostics Inc on 31/03/2021 amounted to 0 $. Biomark Diagnostics Inc net income is now -583 977 $. Biomark Diagnostics Inc financial report on the graph shows the dynamics of assets. All information on Biomark Diagnostics Inc total revenue on this chart is created in the form of yellow bars. The value of all Biomark Diagnostics Inc assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-805 414.07 $
-
31/12/2020
0 $
-100 % ↓
-267 823.14 $
-
30/09/2020
0 $
-
-258 532.93 $
-
30/06/2020
0 $
-
-177 323.58 $
-
31/12/2019
363 116.75 $
-
-928 043.19 $
-
30/09/2019
0 $
-
-187 467.51 $
-
30/06/2019
0 $
-
-166 270.77 $
-
31/03/2019
0 $
-
-169 940.79 $
-
Show:
to
Biomark Diagnostics Inc financial report charts
Dates of Biomark Diagnostics Inc finance reports: 31/03/2019, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Biomark Diagnostics Inc for today is 31/03/2021. Operating income Biomark Diagnostics Inc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Biomark Diagnostics Inc is -560 868 $
Biomark Diagnostics Inc quarterly report dates
Net income Biomark Diagnostics Inc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Biomark Diagnostics Inc is -583 977 $ Current assets Biomark Diagnostics Inc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Biomark Diagnostics Inc is 923 009 $ Total assets Biomark Diagnostics Inc refers to the total amount of assets owned by a person or entity. Total assets Biomark Diagnostics Inc is 952 939 $
Current cash Biomark Diagnostics Inc - the sum of all of the cash a company has on the date of report. Current cash Biomark Diagnostics Inc is 877 678 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
363 116.75 $
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
363 116.75 $
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-773 542.42 $
-253 330.63 $
-218 575.09 $
-171 725.46 $
-922 635.40 $
-177 966.28 $
-161 268.45 $
-164 123.37 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-805 414.07 $
-267 823.14 $
-258 532.93 $
-177 323.58 $
-928 043.19 $
-187 467.51 $
-166 270.77 $
-169 940.79 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
47 496.48 $
89 158.99 $
20 064.43 $
6 620.10 $
6 054.64 $
5 767.76 $
27 029.33 $
8 530.28 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
773 542.42 $
253 330.63 $
218 575.09 $
171 725.46 $
1 285 752.15 $
177 966.28 $
161 268.45 $
164 123.37 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 273 002.94 $
549 696.07 $
666 968.42 $
722 254.55 $
1 021 451.46 $
107 831.81 $
238 629.87 $
45 515.96 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 314 282.03 $
557 460.89 $
676 101.40 $
735 493.38 $
1 024 802.89 $
110 093.68 $
240 891.73 $
47 777.83 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 210 482.97 $
492 999.03 $
626 896.11 $
696 717.51 $
999 449.27 $
90 044.43 $
213 986.53 $
27 575.48 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
1 473 749.27 $
1 495 374.93 $
1 470 149.59 $
1 729 435.55 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 473 749.27 $
1 495 374.93 $
1 470 149.59 $
1 729 435.55 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
143.81 %
1 358.27 %
610.29 %
3 619.74 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-109 085.50 $
-893 938.63 $
-781 274.14 $
-762 823.37 $
-448 946.38 $
-1 385 281.25 $
-1 229 257.85 $
-1 681 657.72 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
485 915.52 $
-454 842.41 $
56 076.40 $
186 688.27 $
Last revenue report of Biomark Diagnostics Inc was 31/03/2021. According to last financial report total revenue in Biomark Diagnostics Inc was 0 Canadian dollar and changed by -100% since last year. Net income in Biomark Diagnostics Inc was -805 414.07 $ in last quartal, net income changes to 0%.
